Medicinal products for obstructive airway diseases (№2836794)

03 oct

Number: 2836794

Country: Spain

Source: TED


Link to original

To view links to the source need to register

Publication date


03-10-2017

Description


  1. Section I
    1. Name and addresses
      Gerencia Regional de Salud
      Paseo Zorrilla, n.º 1
      Valladolid
      47007
      Spain
      Telephone: +34 983413600 /806458
      E-mail: [email protected]
      Fax: +34 983418856
    2. Type of the contracting authority:
      Regional or local authority
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Suministro del medicamento cuyo principio activo es Idursulfasa, destinado a los Complejos Asistenciales de Salamanca y Zamora y Hospitales Universitarios Río Hortega y Clínico Universitario de Valladolid.


        Reference number: 147/2017
      2. Main CPV code:
        33673000
      3. Type of contract:
        Supplies
      4. Short description:

        Suministro del medicamento cuyo principio activo es Idursulfasa, destinado a los Complejos Asistenciales de Salamanca y Zamora y Hospitales Universitarios Río Hortega y Clínico Universitario de Valladolid.


      5. Information about lots:
        This contract is divided into lots: no
      6. Total value of the procurement:
        Value excluding VAT: 2 350 404.00 EUR
    2. Description
      1. Title:
      2. Additional CPV code(s):

      3. Place of performance:
      4. Description of the procurement:

        Suministro del medicamento cuyo principio activo es Idursulfasa, destinado a los Complejos Asistenciales de Salamanca y Zamora y Hospitales Universitarios Río Hortega y Clínico Universitario de Valladolid.


      5. Award criteria:
      6. Information about options:
        Options: no
      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
  3. Section IV
    1. Description:
      1. Type of procedure:
      2. Information about a framework agreement or a dynamic purchasing system:
      3. Information about electronic auction:
      4. Information about the Government Procurement Agreement (GPA):
        The procurement is covered by the Government Procurement Agreement: yes
    2. Administrative information:
      1. Previous publication concerning this procedure:
      2. Information about termination of dynamic purchasing system:
      3. Information about termination of call for competition in the form of a prior information notice:
  4. Section V
    1. Contract No: 1
      Lot No: 1
      Title:

      Suministro del medicamento cuyo principio activo es Idursulfasa, destinado a los Complejos Asistenciales de Salamanca y Zamora y Hospitales Universitarios Río Hortega y Clínico Universitario de Valladolid


    2. Award of contract
      1. Date of conclusion of the contract: 2017-09-15
      2. Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 1
        The contract has been awarded to a group of economic operators: no
      3. Name and address of the contractor:
        Shire Pharmaceuticals Iberica, S.L.
        B82526773
        Madrid
        28042
        Spain
        The contractor is an SME: yes
      4. Information on value of the contract/lot (excluding VAT):
        Initial estimated total value of the contract/lot: 5 000 662.17 EUR
        Total value of the contract/lot: 2 350 404.00 EUR
      5. Information about subcontracting:

  5. Section VI
    1. Additional information

      En el valor estimado están incluidas las posibles prórrogas por el plazo máximo de 1 año.


    2. Procedures for review
      1. Review body
        Tribunal Administrativo de Recursos Contractuales de Castilla y León
        Plaza de la Catedral
        Zamora
        49001
        Spain
      2. Body responsible for mediation procedures

      3. Service from which information about the review procedure may be obtained

    3. Date of dispatch of this notice
      2017-09-28